Skip to main content
. Author manuscript; available in PMC: 2009 Nov 9.
Published in final edited form as: Am J Hematol. 2009 Feb;84(2):71–73. doi: 10.1002/ajh.21328

Figure 1.

Figure 1

Changes in serum BLyS after rituximab treatment (A) Serum levels before (pre) and 1 month after (post) four doses of rituximab in patients with follicular Grade 1 lymphoma receiving rituximab as their initial therapy. Dark bars are the mean value for the group. (B) Change in serum BLyS level for each individual patient before (pre) and after (post) rituximab treatment.